Abstract
The RhI complexes of chiral secondary phosphine oxide ligands have been disclosed to be efficient for the catalytic asymmetric hydrogenation of α-arylacrylic and β-arylbut-3-enoic acids, providing the corresponding chiral α-arylpropanoic and β-arylbutanoic acids in excellent yields with up to 97% ee, including several anti-inflammatory drugs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
